Psoriasis vs Eczema: How to Tell Them Apart — And Why the Diagnosis Matters

Psoriasis and eczema are both inflammatory skin conditions, and both involve abnormal immune activity. But the immune mechanism is different — and this difference explains why the treatments are different.

Psoriasis — the Th17/Th1 driven condition: in psoriasis, the primary immune abnormality involves Th17 and Th1 T-cells producing cytokines (particularly IL-17, IL-23, TNF-alpha) that signal the skin cells (keratinocytes) to proliferate at 4-10 times the normal rate. The characteristic silver-scaled plaques of psoriasis are the result of this rapid, abnormal keratinocyte turnover. Psoriasis is an autoimmune condition — the immune system is attacking the body's own skin tissue through a specific cytokine cascade.

Eczema (atopic dermatitis) — the Th2 driven condition: eczema involves a different immune pathway, primarily Th2 T-cells producing IL-4, IL-13, and IL-31. This creates a different pattern of inflammation — focused on the skin barrier disruption and allergic-type hypersensitivity response. Eczema is closely associated with atopy — the tendency to develop allergic conditions. Approximately 50-70% of eczema patients have or develop associated allergic rhinitis (hayfever), asthma, or food allergies.

Why this distinction determines treatment: the specific cytokines driving each condition are different. Treatments that target the Th2 pathway (effective in eczema — dupilumab, for example, blocks IL-4 and IL-13) do not work in psoriasis. Treatments that target the Th17/Th1 pathway (effective in psoriasis — secukinumab blocks IL-17, ustekinumab blocks IL-23) do not work in eczema. Standard topical steroids reduce inflammation in both — which is why they provide temporary relief in both conditions and often blur the diagnosis. The underlying disease continues regardless.

The practical consequence: a patient who has psoriasis but is managed as eczema typically receives emollients, antihistamines, and topical steroids — appropriate for eczema but not addressing the psoriasis-specific immune process. When the steroids are stopped, psoriasis rebounds often worse than before (rebound phenomenon). This cycle — cream applied, briefly better, stopped, worse — is one of the patterns that suggests the diagnosis may be psoriasis rather than eczema.

The appearance of the skin lesions is the most reliable first-pass distinction between psoriasis and eczema, though it is not infallible.

Psoriasis lesions:

Eczema lesions:

The itch quality — a useful distinguishing feature: psoriasis itch tends to be moderate, persistent, and often worse at night when the skin dries. Eczema itch is classically more intense, paroxysmal (comes in waves), and can be severe enough to prevent sleep. The phrase "the itch that rashes" is sometimes applied to eczema — the itching triggers the rash more than the rash causes the itch.

Nail changes: psoriasis frequently affects the nails — pitting (small ice-pick like holes), oil drop sign (salmon-coloured spot under the nail), and onycholysis (nail lifting from the nail bed). These nail changes are specific to psoriasis. Eczema can cause nail ridging and roughness, but the specific psoriatic nail findings are not seen in eczema.

The location of skin lesions on the body is one of the most reliable ways to distinguish psoriasis from eczema without any special tests.

Psoriasis — classic locations:

Eczema — classic locations:

The extensor-versus-flexor distinction is the most useful single differentiating feature in body distribution:

Understanding triggers is both diagnostically useful and clinically important for management.

Psoriasis triggers:

Eczema triggers:

The temperature pattern is a useful clinical clue: if skin condition consistently worsens in summer heat and sweating, and improves in winter — more likely eczema. If consistently worse in winter (cold, dry) and better in summer sun — more likely psoriasis.

Age of onset and associated conditions provide useful diagnostic context.

Psoriasis — demographics and associations:

Eczema — demographics and associations:

The diagnostic implication: a child with skin patches and a family history of asthma and hay fever — strongly suggests eczema. An adult with new skin patches, no childhood history, and a family member with psoriasis — strongly suggests psoriasis.

The treatment approaches for psoriasis and eczema share some overlap (both use moisturisers and topical steroids) but diverge significantly for anything beyond basic skin care.

Shared approaches:

Psoriasis-specific treatments:

Eczema-specific treatments:

The most commonly confused treatment situation: topical steroid use in both conditions. Steroids work in both — temporarily. In psoriasis, long-term topical steroid use causes thinning, then the steroid loses effectiveness (tachyphylaxis), and stopping triggers rebound that can be severe. In eczema, the same concerns exist. But the alternatives differ completely — a dermatologist or specialist managing each condition long-term needs to know which disease they are treating.

In constitutional homoeopathic practice, the distinction between psoriasis and eczema matters as much as it does in conventional dermatology — perhaps more, because the constitutional picture of each condition is distinctly different.

A psoriasis patient and an eczema patient presenting with skin lesions might both have red, scaly patches on examination. But the constitutional totality is different: the psoriasis patient may have a history of streptococcal triggers, a family history of psoriasis, associated nail changes, clear winter worsening, and an absence of atopic associations. The eczema patient typically has a different history — childhood onset, atopic family background, weeping lesions, allergen triggers, summer worsening.

These different constitutional pictures lead to different remedy families and different prescriptions in homoeopathic practice. A prescription that would be appropriate for constitutional psoriasis would not be appropriate for constitutional eczema — despite both presenting with skin pathology.

This is why patients who have been managed for years under the wrong diagnosis — treated for eczema when they actually have psoriasis, or vice versa — may have had limited response to constitutional homoeopathic treatment tried previously, even with an experienced homoeopath. The starting point of any constitutional treatment is correct disease identification.

If you have been managing a chronic skin condition and are uncertain whether it is psoriasis or eczema — the first step before any constitutional treatment is clarity on diagnosis. Dr. Shadab Khan evaluates the complete clinical picture in consultation and can guide both diagnosis and treatment planning.

WhatsApp 8983458889 — online India-wide.